SCHEMBL23348308

SCHEMBL23348308

N#Cc1c(F)c(-n2c3ccc(-c4ccccc4)cc3c3ccc(-c4ccccc4)cc32)cc(-n2c3ccc(-c4ccccc4)cc3c3ccc(-c4ccccc4)cc32)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HIF1A Q16665 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
KDM4A O75164 1/20 0.34
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
TSPO P30536 1/20 0.32
ADORA1 P30542 3/20 0.32
ADORA2A P29274 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
HPGD P15428 2/20 0.32
MAPK1 P28482 1/20 0.32
PGR P06401 1/20 0.32
SQOR Q9Y6N5 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA4 P48058 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23348232 0.90 PDE1C (0.33) KDM5BSMN1; SMN2HIF1AKDM4AALDH1A1
SCHEMBL23348310 0.87 PGR (0.38) SMN1; SMN2CYP11B1CYP11B2TSPOALDH1A1
SCHEMBL23348461 0.87 PGR (0.36) KDM5BSMN1; SMN2HIF1ACYP11B1CYP11B2
SCHEMBL23348303 0.87 KDM5B (0.34) KDM5BSMN1; SMN2HIF1ACYP11B1CYP11B2
SCHEMBL16122026 0.87 SMN1; SMN2 (0.37) KDM5BSMN1; SMN2HIF1ACYP11B1CYP11B2
SCHEMBL16122020 0.87 CYP11B1 (0.37) KDM5BSMN1; SMN2HIF1ACYP11B1CYP11B2
SCHEMBL23348456 0.85 SMN1; SMN2 (0.45) KDM5BSMN1; SMN2HIF1AKDM4AESR1
SCHEMBL23348520 0.85 KDM5B (0.36) KDM5BSMN1; SMN2HIF1AKDM4AESR1
SCHEMBL23348236 0.85 ADORA1 (0.39) KDM5BSMN1; SMN2HIF1ACYP11B1CYP11B2
SCHEMBL23348230 0.85 PGR (0.37) CYP11B1CYP11B2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CCND2, CCND1, CRY1 KDM5B 3881/4885SMN1; SMN2 2697/4885HIF1A 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.